This indicates that the primary role of these inhibitors on PLEKHA1-TACC2 positive tumor progression likely involves the inhibition of vascular mimicry, which might be independent of the inhibition of cell proliferation. This evidence concerns the gene PLEKHA1 and neoplasm.